183 related articles for article (PubMed ID: 21203530)
1. Superantigens increase the survival of mice bearing T cell lymphomas by inducing apoptosis of neoplastic cells.
Mundiñano J; Berguer PM; Cabrera G; Lorenzo D; Nepomnaschy I; Piazzon I
PLoS One; 2010 Dec; 5(12):e15694. PubMed ID: 21203530
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-mediated inhibition of human T-cell acute lymphoblastic leukemia upon treatment with
Duarte A; Montagna DR; Pastorini M; Alemán M
Front Immunol; 2023; 14():1176432. PubMed ID: 37377961
[TBL] [Abstract][Full Text] [Related]
3. [Viral superantigens].
Us D
Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
[TBL] [Abstract][Full Text] [Related]
4. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.
Hong SC; Waterbury G; Janeway CA
J Exp Med; 1996 Apr; 183(4):1437-46. PubMed ID: 8666902
[TBL] [Abstract][Full Text] [Related]
5. Clonal deletion of T cell repertoires with specific T cell receptor Vβ chains by two endogenous superantigens in NC/Nga mice.
Ohkusu-Tsukada K; Tsukada T; Takahashi K
Biosci Biotechnol Biochem; 2017 Nov; 81(11):2160-2163. PubMed ID: 28934904
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element.
Matsuzawa A; Yasuda T; Zhang Y; Nagase H; Yoshimoto T; Kimura M; Tsubura A
Viral Immunol; 2000; 13(3):297-311. PubMed ID: 11016595
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.
Labrecque N; Thibodeau J; Mourad W; Sékaly RP
J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467
[TBL] [Abstract][Full Text] [Related]
8. A novel method for modification of tumor cells with bacterial superantigen with a heterobifunctional cross-linking agent in immunotherapy of cancer.
Shimizu M; Matsuzawa A; Takeda Y
Mol Biotechnol; 2003 Sep; 25(1):89-94. PubMed ID: 13679639
[TBL] [Abstract][Full Text] [Related]
9. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
Held W; Waanders GA; MacDonald HR; Acha-Orbea H
Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
[TBL] [Abstract][Full Text] [Related]
10. Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.
Lombard C; McKallip RJ; Hylemon PB; Nagarkatti PS; Nagarkatti M
Clin Immunol; 2003 Nov; 109(2):144-53. PubMed ID: 14597213
[TBL] [Abstract][Full Text] [Related]
11. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand.
Renno T; Hahne M; Tschopp J; MacDonald HR
J Exp Med; 1996 Feb; 183(2):431-7. PubMed ID: 8627156
[TBL] [Abstract][Full Text] [Related]
13. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
Torres BA; Griggs ND; Johnson HM
Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
[TBL] [Abstract][Full Text] [Related]
14. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.
Marrack P; Winslow GM; Choi Y; Scherer M; Pullen A; White J; Kappler JW
Immunol Rev; 1993 Feb; 131():79-92. PubMed ID: 8387458
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P; Lombardi G; Deroche A; Francisco MV; Piazzon I
Scand J Immunol; 1999 Mar; 49(3):269-77. PubMed ID: 10102644
[TBL] [Abstract][Full Text] [Related]
16. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
17. A maternally inherited superantigen encoded by a mammary tumour virus.
Marrack P; Kushnir E; Kappler J
Nature; 1991 Feb; 349(6309):524-6. PubMed ID: 1846947
[TBL] [Abstract][Full Text] [Related]
18. Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells.
Boshell M; McLeod J; Walker L; Hall N; Patel Y; Sansom D
Immunology; 1996 Apr; 87(4):586-92. PubMed ID: 8675213
[TBL] [Abstract][Full Text] [Related]
19. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
Wrona TJ; Lozano M; Binhazim AA; Dudley JP
J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
[TBL] [Abstract][Full Text] [Related]
20. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
Maillard I; Xenarios I; Diggelmann H; Orbea HA
Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
